Prefilled Syringes Market, by Material (Glass, Plastic/Polymer), by Drug Type (Biologics, Vaccines, Insulin, Anticoagulants, Flush Saline Syringes and Others), by Design (Single-chamber, Dual-chamber, and Multi-chambered), by Product Type (Staked in-needle pre-filled syringes and Needle-free pre-filled syringes), by Usability (Disposable and Reusable), by Manufacturing Method (Captive and Merchant), by End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.
Market Dynamics
Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period (2023-2030). Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.
The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.
Key features of the study:
This report provides in-depth analysis of the global prefilled syringes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prefilled syringes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market
Detailed Segmentation:
Global Prefilled Syringes Market, By Material:
Glass
Plastic/Polymer
Global Prefilled Syringes Market, By Drug Type:
Biologics
Monoclonal Antibodies
Blood Products
Others (Erythropoietin, Therapeutic proteins, among others)
Vaccines
Conjugated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Others (Virus-like particles (VLPs), Viral vector vaccines)
Insulin
Anticoagulants
Flush Saline Syringes
Others
Global Prefilled Syringes Market, By Design:
Single-chamber
Dual-chamber
Multi-chambered
Global Prefilled Syringes Market, By Product Type:
Staked in-needle pre-filled syringes
Needle-free pre-filled syringes
Global Prefilled Syringes Market, By Usability:
Disposable
Reusable
Global Prefilled Syringes Market, By Manufacturing Method:
Captive
Merchant
Global Prefilled Syringes Market, By End User:
Hospital
Clinics
Ambulatory Surgical Centers
Others
Global Prefilled Syringes Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Gerresheimer AG
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Becton, Dickinson and Company
West Pharmaceutical Services, Inc.
Terumo Corporation
Nipro Europe Group Companies
B. Braun SE
Sanofi
GSK plc.
Pfizer Inc.
Bayer AG
Polymedicure
Amsino International, Inc.
Leeford Healthcare Limited
Torrent Pharmaceuticals Ltd.
Regeneron Pharmaceuticals Inc.
Ypsomed AG
SOL-Millennium
Stevanato Group S.p.A.
“*” marked represents similar segmentation in other categories in the respective section.